Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke
Study Details
Study Description
Brief Summary
Comparison of the experimental group that applied the speed of the robot-assisted gait training constantly and the control group that applied the gradual increase of the speed of the robot-assisted gait training.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Constant gait speed group experimental group that applied the speed of the robot-assisted gait training constantly |
Other: Constant gait speed group
The speed of the robot-assisted gait treatment is constantly applied for 5 times a week for 2 weeks.
|
Other: Increasing gait speed group control group that applied the gradual increase of the speed of the robot-assisted gait training |
Other: Increasing gait speed group
The speed of the robot-assisted gait treatment is gradually increase for 5 times a week for 2 weeks.
|
Outcome Measures
Primary Outcome Measures
- Energy expenditure (EE) [2 weeks after baseline]
EE(kcal/min): energy expenditure per minute
Secondary Outcome Measures
- Energy expenditure (EE) [baseline, 1 weeks after baseline, 3 weeks after baseline]
EE(kcal/min): energy expenditure per minute
- Heart rate (HR) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
Cardiac frequency
- Volume of Oxygen (VO2) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
O2 consumption/1min
- Respiratory Quotient (R) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
Respiratory quotient
- Metabolic equivalent (METS) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
the amount of oxygen consumed while sitting at rest and is equal to 3.5 ml O2 per kg body weight x min
- oxygenated hemoglobin (OxyHb) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
oxygenated hemoglobin concentration of cortical activation
- deoxygenated hemoglobin (DeoxyHb) [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
deoxygenated hemoglobin concentration of cortical activation
- Lower extremity Fugl-Meyer Assessment [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
Fugl-Meyer Assessment uses to examine the motor function and coordination of affected lower extremity. It includes 17 items of a 3-point ordinal scale, ranging 0-34, with higher scores indicating lower impairment.
- Functional Ambulation Category [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
Functional Ambulation Category is used to assess gait ability with 6 levels ranging from 0 to 5 on the basis of the amount of physical support required, regardless of use of an assistive device
- 10m walk test [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
10m walk test is used to examine gait speed, in which participant was asked to walk on a 14 meter of walkway wearing harness with two conditions; with the fastest speed or with self-selected comfortable speed.
- timed up and go test [baseline, 1 weeks after baseline, 2 weeks after baseline, 3 weeks after baseline]
simple test used to assess a person's mobility and requires both static and dynamic balance
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Hemiplegic patients secondary to first cerebrovascular accidents
-
Functional ambulation category score ≥ 3
Exclusion Criteria:
-
History of surgery of affected lower limb
-
Fracture of affected lower limb
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | National Rehabilitation Center | Seoul | Korea, Republic of | 142884 |
Sponsors and Collaborators
- National Rehabilitation Center, Seoul, Korea
Investigators
- Principal Investigator: Joon-Ho Shin, MS, National Rehabilitation Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NRC-2019-01-002